Beta Bionics (BBNX) Other financing activities (2024 - 2026)

Beta Bionics (BBNX) posted Other financing activities of $1.8 million for Q2 2026, up 189.09% sequentially from $623000.0 in Q1 2026.

Beta Bionics (BBNX) Other financing activities (2024 - 2026) Analysis & Trends

Beta Bionics has reported Other financing activities for 3 years, with the latest figure at $1.8 million in Q2 2026.

Quarterly Other financing activities changed N/A year-over-year to $1.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.4 million (down 84.53% YoY) and the FY2025 annual result came in at $15.6 million, up 17417.98% from the prior year.
Other financing activities improved to $1.8 million in Q2 2026 per BBNX's latest filing, from $623000.0 in the prior quarter.
Over five years, Other financing activities peaked at $15.6 million in Q1 2025 and troughed at $6000.0 in Q1 2024.
A 3-year average of $2.6 million and a median of $40000.0 in 2024 frame the typical range for Other financing activities.
The sharpest annual moves came in 2025 and 2026: Other financing activities jumped 259750.0% in 2025, then tumbled 96.0% in 2026.
Over 3 years, Other financing activities stood at $37000.0 in 2024, then jumped by 42037.84% to $15.6 million in 2025, then slumped by 88.45% to $1.8 million in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $1.8 million, $623000.0, and $15.6 million for Q2 2026, Q1 2026, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.49 Bn	193.88 Bn	7.27 Bn
2	Stryker	127.80 Bn	124.32 Bn	4.50 Bn
3	Medtronic	118.98 Bn	109.76 Bn	6.41 Bn
4	Boston Scientific	73.58 Bn	73.04 Bn	3.85 Bn
5	Edwards Lifesciences	51.93 Bn	47.68 Bn	1.35 Bn
6	Dexcom	34.34 Bn	32.39 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.66 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.07 Bn	22.59 Bn	684.20 Mn
10	Beta Bionics	824.53 Mn	644.04 Mn	18.90 Mn

Download Data